Planet 13 Holdings (PLNH) Other Operating Expenses (2022 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Other Operating Expenses of -$969876.0 for Q1 2026, up 28.43% year-over-year from -$755151.1 in Q1 2025, and down 209.97% quarter-over-quarter from $881912.0 in Q4 2025.
Planet 13 Holdings (PLNH) Other Operating Expenses (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Other Operating Expenses for 5 consecutive years, with -$969876.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 28.43% year-over-year to -$969876.0; the TTM figure through Mar 2026 stood at $27.9 million (up 40.89% YoY), while the FY2025 annual figure was $33.0 million, up 22.37% from the prior year.
- Other Operating Expenses eased to -$969876.0 in Q1 2026 per PLNH's latest filing, from $881912.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $38.2 million in Q3 2023 and bottomed at -$1.7 million in Q3 2022.
- Historically, Other Operating Expenses has averaged $7.2 million across 5 years, with a median of -$783930.0 in 2024.
- On a YoY basis, Other Operating Expenses climbed as much as 3137.2% in 2025 and fell as far as 178.25% in 2025.
- Planet 13 Holdings' Other Operating Expenses stood at $34.9 million in 2022, then plunged by 75.14% to $8.7 million in 2023, then surged by 138.54% to $20.7 million in 2024, then plunged by 95.75% to $881912.0 in 2025, then slumped by 209.97% to -$969876.0 in 2026.
- Business Quant data shows PLNH's Other Operating Expenses at -$969876.0 in Q1 2026, $881912.0 in Q4 2025, and $29.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.17 Mn |
| Mar 31, 2026 | -969,876.00 |
| Dec 31, 2025 | 881,912.00 |
| Sep 30, 2025 | 29.07 Mn |
| Jun 30, 2025 | -1.08 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Dec 31, 2024 | 20.73 Mn |
| Sep 30, 2024 | -957,206.00 |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | -783,930.00 |
| Dec 31, 2023 | 8.69 Mn |
| Sep 30, 2023 | 38.16 Mn |
| Jun 30, 2023 | -1.34 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | 34.95 Mn |
| Sep 30, 2022 | -1.67 Mn |
| Jun 30, 2022 | -1.60 Mn |
| Mar 31, 2022 | -639,164.00 |